Surgery Could be Beneficial for High-Risk Lung Cancer Patients Deemed Ineligible

This article originally appeared here.
Surgery Could be Beneficial for High-Risk Lung Cancer Patients Deemed Ineligible
Surgery Could be Beneficial for High-Risk Lung Cancer Patients Deemed Ineligible

(HealthDay News) -- One in five patients with early-stage non-small-cell lung cancer are deemed high-risk or ineligible for lung surgery, but these patients may benefit from the procedure, according to research published online Nov. 9 in the Annals of Thoracic Surgery.

The study included 490 early-stage lung cancer patients who underwent surgery between 2009 and 2013. Of those, 180 patients were classified as high risk.

High-risk patients had slightly longer hospital stays than standard-risk patients -- five days versus four days, and the postoperative mortality risk was 2 and 1 percent, respectively. Three years after surgery, 59 percent of high-risk patients and 76 percent of standard-risk patients were still alive.

"Importantly, we found that about 20 percent of our patients had cancer that had spread to their lymph nodes, a finding that was unexpected based on the preoperative imaging tests," study leader Manu Sancheti, M.D., from the Emory University School of Medicine in Atlanta, said in a journal news release. "High-risk patients have a new treatment avenue that previously may have been denied to them. A multidisciplinary team should review each case to determine the best treatment plan for individual lung cancer patients."

Abstract
Full Text (subscription or payment may be required)

Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs